About Sunrest Lifescience Limited
Data last updated: 07 December 2025
Sunrest Lifescience Limited is a public limited company based in Ahmadabad City, Gujarat, India. It specialises in wholesale trading and distribution, a part of the broader trading and commerce sector. Incorporated on 30 October 2017, the company has been in operation for over 9 years.
Registered with ROC Ahmedabad under CIN U74999GJ2017PTC099606. Listed.
Capital: an authorised share capital of ₹14 Cr and a paid-up capital of ₹4.29 Cr. It is led by directors including Avani Ashwinkumar Shah and Juhi Sawajani.
Last AGM: 27 September 2025. Financial statements filed for year ended 31 March 2024. Office: Ahmadabad City, Gujarat.
As per the financials filed for FY 2024, the company reported a revenue of ₹29.48 Cr, a growth of 20% compared to the previous year.
The company has a workforce of approximately 140 employees as per the latest available data.
The company is associated with 1 brand - Sunrest Lifescience. As per MCA filings, the company has open charges of ₹14 Cr on record.
The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website sunrestlifescience.com.
-
Email**************
-
Telephone**************
-
Website**************
-
Social Media**************
-
Registered AddressD – 608 West Gate Nr Brooklin Tower, Ymca Club Nr Sg Highway Makarba, Ahmadabad City, Gujarat, India – 380051
-
IndustryTrading, Wholesale, Other Wholesale
- Historical Financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Litigation, compliance and MCA filings
- PDF report delivered after checkout
CIN History of Sunrest Lifescience Limited
Sunrest Lifescience Limited has 2 previous CINs, indicating changes in the company's corporate structure or registration details. The current CIN is L74999GJ2017PLC099606, which is the unique identifier assigned by the Registrar of Companies.
| CIN | Status |
|---|---|
| L74999GJ2017PLC099606 | Current |
| U74999GJ2017PTC099606 | Previous |
| U74999GJ2017PLC099606 | Previous |
Associated Brands with Sunrest Lifescience Limited
Sunrest Lifescience Limited operates one associated brand: SUNREST LIFESCIENCE. These brands represent Sunrest Lifescience Limited's diversified market presence and brand portfolio.
| Brand | Description | Website |
|---|---|---|
| Healthcare and wellness products are offered via an online platform. | sunrestlifescience.com |
Business Activity of Sunrest Lifescience Limited
Sunrest Lifescience Limited is engaged in the principal business activity of trade, with detailed activities including wholesale trading.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading | ********* |
Board of Directors of Sunrest Lifescience Limited
Sunrest Lifescience Limited is currently managed by 6 directors, with 7 former directors having served the organization. The current Directors play a crucial role in shaping the company's strategic direction and governance.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
|
Avani Ashwinkumar Shah
Also directs:
Kizi Apparels Limited, Ambassador Intra Holdings Limited, Bright Solar Limited and 1 more
|
Director | 01 Mar 2023 | 3 Years 4 Months | Current |
|
Juhi Sawajani
Also directs:
Kizi Apparels Limited, Ambassador Intra Holdings Limited, Bizotic Commercial Limited and 4 more
|
Director | 01 Mar 2023 | 3 Years 4 Months | Current |
| Nikhilkumar Yashvntlal Thakkar | Managing Director | 30 Oct 2017 | 8 Years 8 Months | Current |
| Bharatkumar Vardhilal Thakkar | Director | 15 Mar 2021 | 5 Years 3 Months | Current |
| Amitbhai Shambhulal Thakkar | Whole-Time Director | 30 Oct 2017 | 8 Years 8 Months | Current |
| Bhagyesh Kiritbhai Parekh | Director | 31 Jan 2022 | 4 Years 5 Months | Current |
Financials of Sunrest Lifescience Limited FY 2024 filings available
Sunrest Lifescience Limited reported revenue of ₹29.48 Cr (up 20% YoY) for FY 2024. Profit growth despite declining revenue indicates effective cost management and margin discipline.
| Metrics | ***** | ***** | ***** | ***** | ***** |
|---|---|---|---|---|---|
| Revenue | |||||
| Revenue from Operations | ***** | ***** | ***** | ***** | ***** |
| Revenue Growth % | ***** | ***** | ***** | ***** | ***** |
| Other Income | ***** | ***** | ***** | ***** | ***** |
| Total Revenue | ***** | ***** | ***** | ***** | ***** |
| Expenses | |||||
| Total Expenses | ***** | ***** | ***** | ***** | ***** |
| Raw Material Cost | ***** | ***** | ***** | ***** | ***** |
| Change in Inventory FG | ***** | ***** | ***** | ***** | ***** |
| Change in Inventory WIP | ***** | ***** | ***** | ***** | ***** |
| Purchase of Traded Goods | ***** | ***** | ***** | ***** | ***** |
| Employee Cost | ***** | ***** | ***** | ***** | ***** |
| Managerial Remuneration | ***** | ***** | ***** | ***** | ***** |
| Audit Fees | ***** | ***** | ***** | ***** | ***** |
| Insurance | ***** | ***** | ***** | ***** | ***** |
| Power & Fuel | ***** | ***** | ***** | ***** | ***** |
| Interest | ***** | ***** | ***** | ***** | ***** |
| Depreciation | ***** | ***** | ***** | ***** | ***** |
| Other Expenses | ***** | ***** | ***** | ***** | ***** |
| Profitability | |||||
| EBITDA (Operating Profit) | ***** | ***** | ***** | ***** | ***** |
| Operating Margin % | ***** | ***** | ***** | ***** | ***** |
| Exceptional Items | ***** | ***** | ***** | ***** | ***** |
| Extraordinary Items | ***** | ***** | ***** | ***** | ***** |
| Profit Before Exceptional & Extraordinary Items | ***** | ***** | ***** | ***** | ***** |
| Profit Before Tax | ***** | ***** | ***** | ***** | ***** |
| Tax & Net Profit | |||||
| Tax Expense | ***** | ***** | ***** | ***** | ***** |
| Current Tax | ***** | ***** | ***** | ***** | ***** |
| Deferred Tax | ***** | ***** | ***** | ***** | ***** |
| Profit from Discontinued Operations | ***** | ***** | ***** | ***** | ***** |
| Tax on Discontinued Operations | ***** | ***** | ***** | ***** | ***** |
| Profit | ***** | ***** | ***** | ***** | ***** |
| Net Margin % | ***** | ***** | ***** | ***** | ***** |
| Metrics | ***** | ***** | ***** | ***** | ***** |
|---|---|---|---|---|---|
| Shareholders' Funds | |||||
| Total Shareholders' Funds | ***** | ***** | ***** | ***** | ***** |
| Equity Capital | ***** | ***** | ***** | ***** | ***** |
| Reserves & Surplus | ***** | ***** | ***** | ***** | ***** |
| Money Against Warrants | ***** | ***** | ***** | ***** | ***** |
| Other Equity | ***** | ***** | ***** | ***** | ***** |
| Non-Current Liabilities | |||||
| Total Non-Current Liabilities | ***** | ***** | ***** | ***** | ***** |
| Long-Term Borrowings | ***** | ***** | ***** | ***** | ***** |
| Deferred Tax Liabilities | ***** | ***** | ***** | ***** | ***** |
| Other Non-Current Liabilities | ***** | ***** | ***** | ***** | ***** |
| Long-Term Provisions | ***** | ***** | ***** | ***** | ***** |
| Current Liabilities | |||||
| Total Current Liabilities | ***** | ***** | ***** | ***** | ***** |
| Short-Term Borrowings | ***** | ***** | ***** | ***** | ***** |
| Trade Payables | ***** | ***** | ***** | ***** | ***** |
| Other Current Liabilities | ***** | ***** | ***** | ***** | ***** |
| Short-Term Provisions | ***** | ***** | ***** | ***** | ***** |
| Total Equity & Liabilities | ***** | ***** | ***** | ***** | ***** |
| Non-Current Assets | |||||
| Non-Current Assets | ***** | ***** | ***** | ***** | ***** |
| Tangible Assets | ***** | ***** | ***** | ***** | ***** |
| Intangible Assets | ***** | ***** | ***** | ***** | ***** |
| Capital WIP | ***** | ***** | ***** | ***** | ***** |
| Intangibles Under Dev | ***** | ***** | ***** | ***** | ***** |
| Investments | ***** | ***** | ***** | ***** | ***** |
| Deferred Tax Assets | ***** | ***** | ***** | ***** | ***** |
| LT Loans & Advances | ***** | ***** | ***** | ***** | ***** |
| Other Non-Current Assets | ***** | ***** | ***** | ***** | ***** |
| Current Assets | |||||
| Current Assets | ***** | ***** | ***** | ***** | ***** |
| Current Investments | ***** | ***** | ***** | ***** | ***** |
| Inventories | ***** | ***** | ***** | ***** | ***** |
| Trade Receivables | ***** | ***** | ***** | ***** | ***** |
| Cash & Bank Balance | ***** | ***** | ***** | ***** | ***** |
| ST Loans & Advances | ***** | ***** | ***** | ***** | ***** |
| Other Current Assets | ***** | ***** | ***** | ***** | ***** |
| Total Assets | ***** | ***** | ***** | ***** | ***** |
| Metrics | ***** | ***** | ***** | ***** | ***** |
|---|---|---|---|---|---|
| Cash from Operating Activities (CFO) | |||||
| Profit Before Tax | ***** | ***** | ***** | ***** | ***** |
| Non-Cash Adjustments | ***** | ***** | ***** | ***** | ***** |
| + Interest Expense | ***** | ***** | ***** | ***** | ***** |
| + Depreciation | ***** | ***** | ***** | ***** | ***** |
| +/- Unrealized Forex | ***** | ***** | ***** | ***** | ***** |
| - Dividend Income | ***** | ***** | ***** | ***** | ***** |
| - Interest Income | ***** | ***** | ***** | ***** | ***** |
| +/- Other Non-Cash Items | ***** | ***** | ***** | ***** | ***** |
| Changes in Working Capital | ***** | ***** | ***** | ***** | ***** |
| +/- Inventory | ***** | ***** | ***** | ***** | ***** |
| +/- Debtors | ***** | ***** | ***** | ***** | ***** |
| +/- Creditors | ***** | ***** | ***** | ***** | ***** |
| Reconciliation Adjustments | ***** | ***** | ***** | ***** | ***** |
| Cash Generated from Operations | ***** | ***** | ***** | ***** | ***** |
| Income Taxes Paid | ***** | ***** | ***** | ***** | ***** |
| Net CFO (Cash from Operations) | ***** | ***** | ***** | ***** | ***** |
| Cash from Investing Activities (CFI) | |||||
| Acquisitions & Disposals | ***** | ***** | ***** | ***** | ***** |
| Disposal of Subsidiaries | ***** | ***** | ***** | ***** | ***** |
| Acquisition of Subsidiaries | ***** | ***** | ***** | ***** | ***** |
| Capex | ***** | ***** | ***** | ***** | ***** |
| Purchase of Fixed Assets | ***** | ***** | ***** | ***** | ***** |
| Sale of Fixed Assets | ***** | ***** | ***** | ***** | ***** |
| Other Investing Cash Flows | ***** | ***** | ***** | ***** | ***** |
| Net CFI (Cash from Investing) | ***** | ***** | ***** | ***** | ***** |
| Cash from Financing Activities (CFF) | |||||
| Equity Issuance | ***** | ***** | ***** | ***** | ***** |
| Debt Raised | ***** | ***** | ***** | ***** | ***** |
| Debt Repaid | ***** | ***** | ***** | ***** | ***** |
| Dividends Paid | ***** | ***** | ***** | ***** | ***** |
| Interest Paid | ***** | ***** | ***** | ***** | ***** |
| Net CFF (Cash from Financing) | ***** | ***** | ***** | ***** | ***** |
| Net Cash Position | |||||
| Net Change in Cash (Pre-Forex) | ***** | ***** | ***** | ***** | ***** |
| Closing Cash & Equivalents | ***** | ***** | ***** | ***** | ***** |
| Metrics | ***** | ***** | ***** | ***** | ***** |
|---|---|---|---|---|---|
| Liquidity | |||||
| Current Ratio | ***** | ***** | ***** | ***** | ***** |
| Quick Ratio | ***** | ***** | ***** | ***** | ***** |
| Cash Ratio | ***** | ***** | ***** | ***** | ***** |
| Efficiency | |||||
| Inventory Days | ***** | ***** | ***** | ***** | ***** |
| Debtor Days | ***** | ***** | ***** | ***** | ***** |
| Creditor Days | ***** | ***** | ***** | ***** | ***** |
| Cash Conversion Cycle | ***** | ***** | ***** | ***** | ***** |
| Asset Turnover | ***** | ***** | ***** | ***** | ***** |
| Profitability | |||||
| Net Profit Margin % | ***** | ***** | ***** | ***** | ***** |
| Operating Margin % | ***** | ***** | ***** | ***** | ***** |
| ROE % | ***** | ***** | ***** | ***** | ***** |
| ROCE % | ***** | ***** | ***** | ***** | ***** |
| Net Worth Margin % | ***** | ***** | ***** | ***** | ***** |
| Growth | |||||
| Revenue Growth % | ***** | ***** | ***** | ***** | ***** |
| Leverage | |||||
| Equity Multiplier | ***** | ***** | ***** | ***** | ***** |
| Debt / EBITDA | ***** | ***** | ***** | ***** | ***** |
| Solvency | |||||
| D/E Ratio | ***** | ***** | ***** | ***** | ***** |
| ICR | ***** | ***** | ***** | ***** | ***** |
Consolidated Statements
Income Statement, Balance Sheet, Cash Flow & Ratios available in the full report.
Charges & Borrowings of Sunrest Lifescience Limited
| Date | Lender | Amount | Status |
|---|---|---|---|
| 05 Jun 2025 | Bank of India | ₹9.9 Cr | Open |
| 25 Oct 2024 | Others | ₹1.1 Cr | Open |
| 18 Nov 2023 | Axis Bank Limited | ₹3 Cr | Open |
Total charge records: 3 View all charges
Employees and EPFO Compliance at Sunrest Lifescience Limited
View historical data on people associated with Sunrest Lifescience Limited, including employment history and EPFO contributions.
Employee Count & EPFO Data of Sunrest Lifescience Limited
Access employee headcount trends, monthly PF payment records, EPFO establishment details, and compliance data.
GST Compliance of Sunrest Lifescience Limited
GSTIN & GST Filing Data of Sunrest Lifescience Limited
Access GSTIN registrations, state-wise filing compliance, HSN/SAC codes, and detailed goods & services data.
Credit Ratings, Litigation & Regulatory Alerts for Sunrest Lifescience Limited
Credit Ratings, Legal Cases & Regulatory Alerts of Sunrest Lifescience Limited
Access complete credit rating history, litigation records, regulatory alerts, and compliance data.
MSME Payment Delays by Sunrest Lifescience Limited
MSME Payment Delays by Sunrest Lifescience Limited
Track payments outstanding to micro and small enterprise vendors, as disclosed in half-yearly MSME-1 returns filed with the MCA.
Subsidiaries & Group Companies of Sunrest Lifescience Limited
Subsidiaries & Group Companies of Sunrest Lifescience Limited
See the full corporate group - holding company, subsidiaries, associates and joint ventures of Sunrest Lifescience Limited with ownership details.
MCA Filings & Documents of Sunrest Lifescience Limited
MCA Filings & Documents of Sunrest Lifescience Limited
Download official documents filed with the Ministry of Corporate Affairs - from incorporation papers to the latest annual filings.
Recent Activity on Sunrest Lifescience Limited
Recent News on Sunrest Lifescience Limited
Frequently Asked Questions about Sunrest Lifescience Limited
Sunrest Lifescience Limited is an active public limited company in the trading sector based in Ahmadabad City, Gujarat, India. It was incorporated on 30 October 2017 (9+ years old) and is registered under CIN L74999GJ2017PLC099606. The company has 140 employees.
Sunrest Lifescience Limited reported revenue of ₹29.48 Cr for FY 2024 (up 20.00% YoY).
The current directors of Sunrest Lifescience Limited are:
The primary industry of Sunrest Lifescience Limited is trading. The company specifically operates in wholesale. The company is currently active in this sector.
Yes, Sunrest Lifescience Limited is a listed company.
Sunrest Lifescience Limited can be reached at the registered office: D – 608 West Gate Nr Brooklin Tower, Ymca Club Nr Sg Highway Makarba, Ahmadabad City, Gujarat, India – 380051, or through the website sunrestlifescience.com.